EOS imaging SA, together with its subsidiaries, develops, markets, and sells medical imaging devices for osteo-articular conditions and orthopedics, and related applications. More Details
Imperfect balance sheet with limited growth.
Share Price & News
How has EOS imaging's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: EOSG.F has not had significant price volatility in the past 3 months.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: Insufficient data to determine how EOSG.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how EOSG.F performed against the US Market.
Price Volatility Vs. Market
How volatile is EOS imaging's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is EOS imaging undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate EOSG.F's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate EOSG.F's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: EOSG.F is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.
PE vs Market: EOSG.F is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate EOSG.F's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: EOSG.F is good value based on its PB Ratio (3.1x) compared to the US Medical Equipment industry average (3.7x).
How is EOS imaging forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EOSG.F is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: EOSG.F is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: EOSG.F is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: EOSG.F's revenue (33.7% per year) is forecast to grow faster than the US market (9.9% per year).
High Growth Revenue: EOSG.F's revenue (33.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if EOSG.F's Return on Equity is forecast to be high in 3 years time
How has EOS imaging performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: EOSG.F is currently unprofitable.
Growing Profit Margin: EOSG.F is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: EOSG.F is unprofitable, and losses have increased over the past 5 years at a rate of 28.2% per year.
Accelerating Growth: Unable to compare EOSG.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EOSG.F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-0.2%).
Return on Equity
High ROE: EOSG.F has a negative Return on Equity (-152.58%), as it is currently unprofitable.
How is EOS imaging's financial position?
Financial Position Analysis
Short Term Liabilities: EOSG.F's short term assets (€44.6M) exceed its short term liabilities (€23.1M).
Long Term Liabilities: EOSG.F's short term assets (€44.6M) exceed its long term liabilities (€29.7M).
Debt to Equity History and Analysis
Debt Level: EOSG.F's debt to equity ratio (218.4%) is considered high.
Reducing Debt: EOSG.F's debt to equity ratio has increased from 14.1% to 218.4% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: EOSG.F has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: EOSG.F has less than a year of cash runway if free cash flow continues to reduce at historical rates of 5.9% each year
What is EOS imaging current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate EOSG.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate EOSG.F's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if EOSG.F's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if EOSG.F's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of EOSG.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Mike Lobinsky is Chief Executive Officer of EOS imaging SA since January 1, 2019 and serves as its Director. He was President of North America at EOS imaging SA since joining in August 2017 until Decem ...
|CEO & Director||1.67yrs||no data||0.27% |
|Chief Financial Officer||1.83yrs||no data||no data|
|Chief Operating Officer||2.92yrs||no data||no data|
|Vice President of Global Marketing||0.67yr||no data||no data|
|Director of Human Resources||0.67yr||no data||no data|
|Chief Medical Officer||5.08yrs||no data||no data|
|Field Maintenance Director||no data||no data||no data|
Experienced Management: EOSG.F's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
|CEO & Director||1.67yrs||no data||0.27% |
|Director||no data||€682.70k||1.46% |
|Chairman of the Board||5.17yrs||€65.00k||0.026% |
|Independent Director||8.25yrs||€30.00k||no data|
|Director||1.75yrs||no data||no data|
Experienced Board: EOSG.F's board of directors are considered experienced (5.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
EOS imaging SA's company bio, employee growth, exchange listings and data sources
- Name: EOS imaging SA
- Ticker: EOSG.F
- Exchange: OTCPK
- Founded: 1989
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: €37.627m
- Listing Market Cap: €44.059m
- Shares outstanding: 26.50m
- Website: https://www.eos-imaging.com
Number of Employees
- EOS imaging SA
- 10, rue Mercœur
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|EOSI||ENXTPA (Euronext Paris)||Yes||Common Stock||FR||EUR||Feb 2012|
|0QAR||LSE (London Stock Exchange)||Yes||Common Stock||GB||EUR||Feb 2012|
|EOSIP||BATS-CHIXE (BATS 'Chi-X Europe')||Yes||Common Stock||GB||EUR||Feb 2012|
|EOSG.F||OTCPK (Pink Sheets LLC)||Yes||Common Stock||US||USD||Feb 2012|
|EO8||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Feb 2012|
EOS imaging SA, together with its subsidiaries, develops, markets, and sells medical imaging devices for osteo-articular conditions and orthopedics, and related applications. It offers EOS, an imaging syst ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/23 06:20|
|End of Day Share Price||2020/09/09 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.